HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.

Abstract
Glucagon-like peptide-2 (GLP-2) is a nutrient-regulated intestinotrophic hormone derived from proglucagon in the distal intestine. Enteral nutrients (EN) potentiate the action of GLP-2 to reverse parenteral nutrition (PN)-induced mucosal hypoplasia. The objective was to determine what enteral protein component, casein, soy, or whey protein, potentiates the intestinal growth response to GLP-2 in rats with PN-induced mucosal hypoplasia. Rats received PN and continuous intravenous infusion of GLP-2 (100 microg/kg/day) for 7 days. Six EN groups received PN+GLP-2 for days 1-3 and partial PN+GLP-2 plus EN for days 4-7. EN was provided by ad libitum intake of a semielemental liquid diet with different protein sources: casein, hydrolyzed soy, whey protein concentrate (WPC), and hydrolyzed WPC+casein. Controls received PN+GLP-2 alone. EN induced significantly greater jejunal sucrase activity and gain of body weight, and improved feed efficiency compared with PN+GLP-2 alone. EN induced greater ileal proglucagon expression, increased plasma concentration of bioactive GLP-2 by 35%, and reduced plasma dipeptidyl peptidase IV (DPP-IV) activity compared with PN+GLP-2 alone, P < 0.05. However, only whey protein, and not casein or soy, potentiated the ability of GLP-2 to reverse PN-induced mucosal hypoplasia and further increase ileal villus height, crypt depth, and mucosa cellularity compared with PN+GLP-2 alone, P < 0.05. The ability of whey protein to induce greater mucosal surface area was associated with decreased DPP-IV activity in ileum and colon compared with casein, soy, or PN+GLP-2 alone, P < 0.05. In conclusion, whey protein potentiates the action of GLP-2 to reverse PN-induced mucosal hypoplasia in association with decreased intestinal DPP-IV activity.
AuthorsXiaowen Liu, Sangita G Murali, Jens J Holst, Denise M Ney
JournalAmerican journal of physiology. Regulatory, integrative and comparative physiology (Am J Physiol Regul Integr Comp Physiol) Vol. 297 Issue 5 Pg. R1554-62 (Nov 2009) ISSN: 1522-1490 [Electronic] United States
PMID19776251 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Glucagon-Like Peptide 2
  • Milk Proteins
  • Whey Proteins
  • Proglucagon
  • Sucrase
  • Dipeptidyl Peptidase 4
Topics
  • Animals
  • Body Weight (physiology)
  • Dipeptidyl Peptidase 4 (metabolism)
  • Dose-Response Relationship, Drug
  • Eating (physiology)
  • Glucagon-Like Peptide 2 (blood, pharmacology)
  • Intestinal Mucosa (drug effects, growth & development, metabolism)
  • Intestines (drug effects, growth & development)
  • Male
  • Milk Proteins (pharmacology)
  • Models, Animal
  • Parenteral Nutrition
  • Proglucagon (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Sucrase (metabolism)
  • Whey Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: